IDEXX Laboratories Inc (IDXX)
508.26
+7.44
(+1.49%)
USD |
NASDAQ |
May 10, 14:50
IDEXX Laboratories Free Cash Flow: 796.79M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 796.79M |
| December 31, 2023 | 772.88M |
| September 30, 2023 | 679.78M |
| June 30, 2023 | 592.76M |
| March 31, 2023 | 455.68M |
| December 31, 2022 | 384.15M |
| September 30, 2022 | 438.12M |
| June 30, 2022 | 429.00M |
| March 31, 2022 | 604.61M |
| December 31, 2021 | 636.00M |
| September 30, 2021 | 662.56M |
| June 30, 2021 | 694.03M |
| March 31, 2021 | 666.24M |
| December 31, 2020 | 540.19M |
| September 30, 2020 | 444.94M |
| June 30, 2020 | 366.23M |
| March 31, 2020 | 285.96M |
| December 31, 2019 | 303.93M |
| September 30, 2019 | 290.24M |
| June 30, 2019 | 274.29M |
| March 31, 2019 | 262.15M |
| December 31, 2018 | 277.15M |
| September 30, 2018 | 280.46M |
| June 30, 2018 | 296.02M |
| March 31, 2018 | 300.12M |
| Date | Value |
|---|---|
| December 31, 2017 | 296.57M |
| September 30, 2017 | 283.38M |
| June 30, 2017 | 277.05M |
| March 31, 2017 | 276.70M |
| December 31, 2016 | 274.16M |
| September 30, 2016 | 252.16M |
| June 30, 2016 | 220.24M |
| March 31, 2016 | 181.63M |
| December 31, 2015 | 138.88M |
| September 30, 2015 | 84.24M |
| June 30, 2015 | 104.10M |
| March 31, 2015 | 115.44M |
| December 31, 2014 | 175.15M |
| September 30, 2014 | 215.13M |
| June 30, 2014 | 201.41M |
| March 31, 2014 | 189.14M |
| December 31, 2013 | 167.36M |
| September 30, 2013 | 172.63M |
| June 30, 2013 | 165.94M |
| March 31, 2013 | 159.32M |
| December 31, 2012 | 163.89M |
| September 30, 2012 | 153.00M |
| June 30, 2012 | 158.70M |
| March 31, 2012 | 156.43M |
| December 31, 2011 | 167.24M |
Free Cash Flow Range, Past 5 Years
274.29M
Minimum
Jun 2019
796.79M
Maximum
Mar 2024
515.92M
Average
497.93M
Median
Free Cash Flow Benchmarks
| Stryker Corp | 2.858B |
| Haemonetics Corp | 128.75M |
| ResMed Inc | 1.071B |
| Steris PLC | 593.99M |
| Zoetis Inc | 1.75B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 198.58M |
| Cash from Investing (Quarterly) | -106.94M |
| Cash from Financing (Quarterly) | -144.07M |
| Free Cash Flow Per Share (Quarterly) | 2.005 |
| Free Cash Flow to Equity (Quarterly) | 170.42M |
| Free Cash Flow to Firm (Quarterly) | 171.09M |
| Free Cash Flow Yield | 1.87% |